Long-Term Surveillance of Ocrelizumab Treated Patients With Multiple Sclerosis (MANUSCRIPT Study)

28/02/2019
14/03/2024
EU PAS number:
EUPAS28619
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data source(s), other

Multiple Sclerosis Documentation System 3D (MSDS3D) Germany, The Big MS Data (BMSD) Group, a collaboration of MS registries, France, Italy, Sweden Denmark, International registry MSBase Australia

Data sources (types)

Disease registry
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No